Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01959217 · ClinicalTrials.gov registry record · NA

Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse

A NA study, sponsored by Wayne State University.

Completed
Registry status
NA
Development phase
104
Enrollment target

NCT01959217 is a NA study that has completed, run by Wayne State University. The registered enrollment target is 104 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01959217, a NA study, has completed, sponsored by Wayne State University.

COMPLETED
Registry status
NA
Development phase
104 participants
Enrollment target

Study Summary

Medication adherence rates among youth living with HIV are inadequate to effectively manage the disease, and novel interventions grounded in basic behavioral sciences are needed. This multi-site phased (3 phases) study plans to translate basic cognitive neuroscience regarding prospective memory (PM) into a more potent adherence intervention for youth living with HIV (YLH). The phases are: Phase 1: To improve PM in basic laboratory tasks in YLH with and without substance abuse. -Hypothesis 1: Manipulations in three theory-based components of PM (strategic encoding, self-monitoring and cue salience) will improve PM within each participant. Phase 2: To conduct proof of concept studies of a text-delivered PM intervention for taking ART in YLH with suboptimal adherence. * Hypothesis 2: Using a multiple baseline across subjects design, adherence to antiretroviral therapy (ART) will improve following initiation of the PM adherence intervention and will be maintained for 6 weeks after tapering of the intervention. * Hypothesis 2a: Similar feasibility, tolerability, and adherence improvement trends will be seen in youth with and without substance problems. Phase 3: To conduct additional proof of concept studies, based on Phase 2 findings, of a text-delivered PM intervention for taking ART in YLH with suboptimal adherence. * Hypothesis 3: Using a multiple baseline across subjects design, adherence to ART will improve following initiation of the PM adherence intervention and will be maintained for 6 weeks after tapering of the intervention. * Hypothesis 3a: Similar feasibility, tolerability, and adherence improvement trends will be seen in youth.

Interventions

  • BEHAVIORAL PM Component Text Reminders

Trial Details

FieldValue
Enrollment Target 104 participants
Start Date 2012-12-13
Est. Completion 2018-09-27
Phase NA

Sponsor

Wayne State University

163 total trials

What the Registry Record Tells You About NCT01959217

The ClinicalTrials.gov registry entry for NCT01959217 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 104 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which PM Component Text Reminders is the first listed.

NCT01959217 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01959217 about?

NCT01959217 is a clinical study titled "Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse". Medication adherence rates among youth living with HIV are inadequate to effectively manage the disease, and novel interventions grounded in basic behavioral sciences are needed. This multi-site phased (3 phases) study plans to translate basic cognitive neuroscience regarding prospective memory (PM)...

What is the current status of trial NCT01959217?

This trial is currently completed. It is a NA study. The enrollment target is 104 participants. The study started on 2012-12-13. Estimated completion is 2018-09-27.

What interventions are being tested in trial NCT01959217?

The interventions under investigation include: PM Component Text Reminders (BEHAVIORAL).

Who is sponsoring clinical trial NCT01959217?

This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.